Below are the most recent publications written about "Drug Resistance, Multiple" by people in Profiles.
-
Zafar A, Lalani FK, Longi AA, Jajja MR, Haider M, Hashmi S, Khan E, Irfan S, Hussain T, Hussain FR, Hasan R, Jabeen K. Increase in Penicillin and multidrug resistance in Streptococcus pneumoniae (1993-2016): Report from a tertiary care hospital laboratory, Pakistan. J Pak Med Assoc. 2021 Dec; 71(12):2726-2730.
-
Safdar N, Sengupta S, Musuuza JS, Juthani-Mehta M, Drees M, Abbo LM, Milstone AM, Furuno JP, Varman M, Anderson DJ, Morgan DJ, Miller LG, Snyder GM. Status of the Prevention of Multidrug-Resistant Organisms in International Settings: A Survey of the Society for Healthcare Epidemiology of America Research Network. Infect Control Hosp Epidemiol. 2017 01; 38(1):53-60.
-
Lockhart SR, Etienne KA, Vallabhaneni S, Farooqi J, Chowdhary A, Govender NP, Colombo AL, Calvo B, Cuomo CA, Desjardins CA, Berkow EL, Castanheira M, Magobo RE, Jabeen K, Asghar RJ, Meis JF, Jackson B, Chiller T, Litvintseva AP. Simultaneous Emergence of Multidrug-Resistant Candida auris on 3 Continents Confirmed by Whole-Genome Sequencing and Epidemiological Analyses. Clin Infect Dis. 2017 Jan 15; 64(2):134-140.
-
Nurmohamed L, Garcia-Bournissen F, Buono RJ, Shannon MW, Finkelstein Y. Predisposition to epilepsy--does the ABCB1 gene play a role? Epilepsia. 2010 Sep; 51(9):1882-5.
-
Lucumi E, Darling C, Jo H, Napper AD, Chandramohanadas R, Fisher N, Shone AE, Jing H, Ward SA, Biagini GA, DeGrado WF, Diamond SL, Greenbaum DC. Discovery of potent small-molecule inhibitors of multidrug-resistant Plasmodium falciparum using a novel miniaturized high-throughput luciferase-based assay. Antimicrob Agents Chemother. 2010 Sep; 54(9):3597-604.
-
Chau M, Christensen JL, Ajami AM, Capizzi RL. Amonafide, a topoisomerase II inhibitor, is unaffected by P-glycoprotein-mediated efflux. Leuk Res. 2008 Mar; 32(3):465-73.
-
Manara MC, Perdichizzi S, Serra M, Pierini R, Benini S, Hattinger CM, Astolfi A, Bagnati R, D'Incalci M, Picci P, Scotlandi K. The molecular mechanisms responsible for resistance to ET-743 (Trabectidin; Yondelis) in the Ewing's sarcoma cell line, TC-71. Int J Oncol. 2005 Dec; 27(6):1605-16.
-
Chano T, Mori K, Scotlandi K, Benini S, Lapucci C, Manara MC, Serra M, Picci P, Okabe H, Baldini N. Differentially expressed genes in multidrug resistant variants of U-2 OS human osteosarcoma cells. Oncol Rep. 2004 Jun; 11(6):1257-63.
-
Manara MC, Serra M, Benini S, Picci P, Scotlandi K. Effectiveness of Type I interferons in the treatment of multidrug resistant osteosarcoma cells. Int J Oncol. 2004 Feb; 24(2):365-72.
-
Berg AT, Vickrey BG, Langfitt JT, Sperling MR, Walczak TS, Shinnar S, Bazil CW, Pacia SV, Spencer SS. The multicenter study of epilepsy surgery: recruitment and selection for surgery. Epilepsia. 2003 Nov; 44(11):1425-33.